Registration of Amyotrophic Lateral Sclerosis: Validity in the Danish National Patient Registry

Lotte Sahin Levison; Peter Jepsen; Henning Andersen

doi:10.2147/clep.s458661

Registration of Amyotrophic Lateral Sclerosis: Validity in the Danish National Patient Registry

Lotte Sahin Levison^*, Peter Jepsen, Henning Andersen

^*Corresponding author for this work

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

1 Citation (Scopus)

Abstract

Purpose: Health care databases are a valuable source for epidemiological research on amyotrophic lateral sclerosis (ALS) if diagnosis codes are valid. We evaluated the validity of the diagnostic codes for ALS in the Danish National Patient Registry (DNPR). Patients and Methods: We obtained data from the DNPR for all adult (>17 years) patients registered with ALS in Denmark between 1987 and 2022 (median population of 4.2 million during the study period). We randomly selected adult patients living in the North Denmark Region and Central Denmark Region (median population 1.4 million), with a primary discharge diagnosis code of ALS, diagnosed at three departments of neurology. We retrieved and reviewed medical records and estimated the positive predictive value (PPV) of the ALS diagnosis. Results: Over 36 years, we identified 5679 patients. From the validation cohort of 300 patients, we were able to retrieve 240 (80%) medical records, and 215 ALS diagnoses were confirmed. The overall positive predictive value was 89.6% (95% confidence interval (CI): 85.1–92.8). The highest PPV was achieved for diagnoses registered for patients aged ≥70 years (93.8; 95% CI: 86.2–97.3) compared to patients <60 years (83.4; 95% CI: 73.3–90.7). Conclusion: We found a high PPV of primary diagnostic codes for ALS from Danish departments of neurology, demonstrating high validity. Thus, the DNPR is a well–suited data source for large-scale epidemiological research on ALS.

Original language	English
Journal	Clinical epidemiology
Volume	16
Pages (from-to)	409-415
Number of pages	7
ISSN	1179-1349
DOIs	https://doi.org/10.2147/clep.s458661
Publication status	Published - Jun 2024

Keywords

amyotrophic lateral sclerosis
epidemiology
international classification of disease codes
positive predictive value
registries

Access to Document

10.2147/clep.s458661

Cite this

@article{c95eafd02fdb45ba8a2db978130c80d8,

title = "Registration of Amyotrophic Lateral Sclerosis: Validity in the Danish National Patient Registry",

abstract = "Purpose: Health care databases are a valuable source for epidemiological research on amyotrophic lateral sclerosis (ALS) if diagnosis codes are valid. We evaluated the validity of the diagnostic codes for ALS in the Danish National Patient Registry (DNPR). Patients and Methods: We obtained data from the DNPR for all adult (>17 years) patients registered with ALS in Denmark between 1987 and 2022 (median population of 4.2 million during the study period). We randomly selected adult patients living in the North Denmark Region and Central Denmark Region (median population 1.4 million), with a primary discharge diagnosis code of ALS, diagnosed at three departments of neurology. We retrieved and reviewed medical records and estimated the positive predictive value (PPV) of the ALS diagnosis. Results: Over 36 years, we identified 5679 patients. From the validation cohort of 300 patients, we were able to retrieve 240 (80%) medical records, and 215 ALS diagnoses were confirmed. The overall positive predictive value was 89.6% (95% confidence interval (CI): 85.1–92.8). The highest PPV was achieved for diagnoses registered for patients aged ≥70 years (93.8; 95% CI: 86.2–97.3) compared to patients <60 years (83.4; 95% CI: 73.3–90.7). Conclusion: We found a high PPV of primary diagnostic codes for ALS from Danish departments of neurology, demonstrating high validity. Thus, the DNPR is a well–suited data source for large-scale epidemiological research on ALS.",

keywords = "amyotrophic lateral sclerosis, epidemiology, international classification of disease codes, positive predictive value, registries",

author = "Levison, {Lotte Sahin} and Peter Jepsen and Henning Andersen",

note = "Publisher Copyright: {\textcopyright} 2024 Levison et al.",

year = "2024",

month = jun,

doi = "10.2147/clep.s458661",

language = "English",

volume = "16",

pages = "409--415",

journal = "Clinical epidemiology",

issn = "1179-1349",

publisher = "Dove Medical Press Ltd",

}

TY - JOUR

T1 - Registration of Amyotrophic Lateral Sclerosis

T2 - Validity in the Danish National Patient Registry

AU - Levison, Lotte Sahin

AU - Jepsen, Peter

AU - Andersen, Henning

PY - 2024/6

Y1 - 2024/6

N2 - Purpose: Health care databases are a valuable source for epidemiological research on amyotrophic lateral sclerosis (ALS) if diagnosis codes are valid. We evaluated the validity of the diagnostic codes for ALS in the Danish National Patient Registry (DNPR). Patients and Methods: We obtained data from the DNPR for all adult (>17 years) patients registered with ALS in Denmark between 1987 and 2022 (median population of 4.2 million during the study period). We randomly selected adult patients living in the North Denmark Region and Central Denmark Region (median population 1.4 million), with a primary discharge diagnosis code of ALS, diagnosed at three departments of neurology. We retrieved and reviewed medical records and estimated the positive predictive value (PPV) of the ALS diagnosis. Results: Over 36 years, we identified 5679 patients. From the validation cohort of 300 patients, we were able to retrieve 240 (80%) medical records, and 215 ALS diagnoses were confirmed. The overall positive predictive value was 89.6% (95% confidence interval (CI): 85.1–92.8). The highest PPV was achieved for diagnoses registered for patients aged ≥70 years (93.8; 95% CI: 86.2–97.3) compared to patients <60 years (83.4; 95% CI: 73.3–90.7). Conclusion: We found a high PPV of primary diagnostic codes for ALS from Danish departments of neurology, demonstrating high validity. Thus, the DNPR is a well–suited data source for large-scale epidemiological research on ALS.

AB - Purpose: Health care databases are a valuable source for epidemiological research on amyotrophic lateral sclerosis (ALS) if diagnosis codes are valid. We evaluated the validity of the diagnostic codes for ALS in the Danish National Patient Registry (DNPR). Patients and Methods: We obtained data from the DNPR for all adult (>17 years) patients registered with ALS in Denmark between 1987 and 2022 (median population of 4.2 million during the study period). We randomly selected adult patients living in the North Denmark Region and Central Denmark Region (median population 1.4 million), with a primary discharge diagnosis code of ALS, diagnosed at three departments of neurology. We retrieved and reviewed medical records and estimated the positive predictive value (PPV) of the ALS diagnosis. Results: Over 36 years, we identified 5679 patients. From the validation cohort of 300 patients, we were able to retrieve 240 (80%) medical records, and 215 ALS diagnoses were confirmed. The overall positive predictive value was 89.6% (95% confidence interval (CI): 85.1–92.8). The highest PPV was achieved for diagnoses registered for patients aged ≥70 years (93.8; 95% CI: 86.2–97.3) compared to patients <60 years (83.4; 95% CI: 73.3–90.7). Conclusion: We found a high PPV of primary diagnostic codes for ALS from Danish departments of neurology, demonstrating high validity. Thus, the DNPR is a well–suited data source for large-scale epidemiological research on ALS.

KW - amyotrophic lateral sclerosis

KW - epidemiology

KW - international classification of disease codes

KW - positive predictive value

KW - registries

UR - http://www.scopus.com/inward/record.url?scp=85196419568&partnerID=8YFLogxK

U2 - 10.2147/clep.s458661

DO - 10.2147/clep.s458661

M3 - Journal article

AN - SCOPUS:85196419568

SN - 1179-1349

VL - 16

SP - 409

EP - 415

JO - Clinical epidemiology

JF - Clinical epidemiology

ER -

Registration of Amyotrophic Lateral Sclerosis: Validity in the Danish National Patient Registry

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this